TY - JOUR
T1 - Geographic variation in human papillomavirus vaccination uptake among 13-17 year old adolescent girls in the United States
AU - Rahman, Mahbubur
AU - McGrath, Christine J.
AU - Berenson, Abbey B.
N1 - Funding Information:
Federal support for this study was provided by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) ( K24 HD04365 , Berenson). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD or the National Institutes of Health. Dr. McGrath is supported by a research career development award ( K12HD052023 : Building Interdisciplinary Research Careers in Women's Health Program-BIRCWH) from the Office of Research on Women's Health (ORWH) , the Office of the Director (OD), the National Institute of Allergy and Infectious Diseases (NIAID) , and NICHD at the National Institutes of Health .
PY - 2014/5/1
Y1 - 2014/5/1
N2 - Geographic variation in provider-verified human papillomavirus (HPV) vaccine uptake among adolescent girls in the US has not been examined. To investigate this, we analyzed 2011 National Immunization Survey-Teen data. Among 13-17 year old girls (n= 11,236), weighted vaccine initiation (48.4%) and completion rates (30.6%) were the lowest in the South when compared to the Northeast (53.4% and 39.9%), Midwest (51.1% and 33.5%) and West (61.6% and 38.7%) (P< .001, both for initiation and completion). Multivariable log-binomial regression analysis indicated that 13-17 year old girls living in the South were less likely to initiate [adjusted prevalence ratio (aPR). = 0.86, 95% confidence interval (CI) 0.75-0.97] and complete (aPR. = 0.83, 95% CI, 0.74-0.93) the HPV vaccine series compared to girls living in the Northeast. Similar differences were observed when the uptake rates in the South were compared to other regions in the US. Intervention programs to increase HPV vaccine uptake and reduce regional disparities are warranted.
AB - Geographic variation in provider-verified human papillomavirus (HPV) vaccine uptake among adolescent girls in the US has not been examined. To investigate this, we analyzed 2011 National Immunization Survey-Teen data. Among 13-17 year old girls (n= 11,236), weighted vaccine initiation (48.4%) and completion rates (30.6%) were the lowest in the South when compared to the Northeast (53.4% and 39.9%), Midwest (51.1% and 33.5%) and West (61.6% and 38.7%) (P< .001, both for initiation and completion). Multivariable log-binomial regression analysis indicated that 13-17 year old girls living in the South were less likely to initiate [adjusted prevalence ratio (aPR). = 0.86, 95% confidence interval (CI) 0.75-0.97] and complete (aPR. = 0.83, 95% CI, 0.74-0.93) the HPV vaccine series compared to girls living in the Northeast. Similar differences were observed when the uptake rates in the South were compared to other regions in the US. Intervention programs to increase HPV vaccine uptake and reduce regional disparities are warranted.
KW - Cervical cancer
KW - Geographic variation
KW - HPV vaccine
KW - Human papillomavirus
KW - NIS-Teen
UR - http://www.scopus.com/inward/record.url?scp=84898426761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898426761&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2014.02.097
DO - 10.1016/j.vaccine.2014.02.097
M3 - Article
C2 - 24637175
AN - SCOPUS:84898426761
SN - 0264-410X
VL - 32
SP - 2394
EP - 2398
JO - Vaccine
JF - Vaccine
IS - 21
ER -